Your browser doesn't support javascript.
loading
Characterization of the mutation spectrum in a Pakistani cohort of type 3 von Willebrand disease.
Ahmed, Shariq; Yadegari, Hamideh; Naz, Arshi; Biswas, Arijit; Budde, Ulrich; Saqlain, Nazish; Amanat, Samina; Tariq, Shehla; Raziq, Fazle; Masood, Shahtaj; Pavlova, Anna; Shamsi, Tahir Sultan; Oldenburg, Johannes.
Afiliação
  • Ahmed S; National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.
  • Yadegari H; Institute of Experimental Haematology and Transfusion Medicine, University Clinics Bonn, Bonn, Germany.
  • Naz A; National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.
  • Biswas A; Institute of Experimental Haematology and Transfusion Medicine, University Clinics Bonn, Bonn, Germany.
  • Budde U; Hämostaseology, Medilys Laborgesellschaft mbH, Hamburg, Germany.
  • Saqlain N; Children Hospital Lahore, Lahore, Pakistan.
  • Amanat S; Atomic Energy Commission Islamabad, Islamabad, Pakistan.
  • Tariq S; Children Hospital Lahore, Lahore, Pakistan.
  • Raziq F; Hayatabad Medical Complex Peshawar, Peshawar, Pakistan.
  • Masood S; Hayatabad Medical Complex Peshawar, Peshawar, Pakistan.
  • Pavlova A; Institute of Experimental Haematology and Transfusion Medicine, University Clinics Bonn, Bonn, Germany.
  • Shamsi TS; National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.
  • Oldenburg J; Institute of Experimental Haematology and Transfusion Medicine, University Clinics Bonn, Bonn, Germany.
Haemophilia ; 25(6): 1035-1044, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31532876
INTRODUCTION: Type 3 von Willebrand disease (VWD), a severe autosomal recessive hereditary bleeding disorder, is described by the virtual absence of von Willebrand factor (VWF). In consanguineous populations, for example Pakistan, the disease is reported with a higher incidence rate than the worldwide prevalence. AIMS: This study aims to characterize molecular pathology and clinical profile of type 3 VWD cohort of Pakistani origin. METHODS: In total, 48 patients were enrolled in the current study. Initially, the index patients (IPs) were evaluated by a standardized questionnaire for recording bleeding manifestations and by performing conventional coagulation tests. The diagnosis of VWD type 3 was confirmed by VWF antigens less than 5 IU/dL. Direct sequencing of VWF gene (VWF) was carried out to identify causative gene variations. We evaluated the potential consequence of novel splice site and missense variations by predictive computational programs and in silico structural analysis. RESULTS: VWF mutations were detected in 46 out of 48 IPs (95.8%), predominantly as homozygous variants. In total, twenty-nine different gene defects were characterized in this cohort from which 10 (34.5%) are novel. The majority of the mutations were null alleles (66%; including gene conversions, nonsense, splice site variations, small deletions and insertions), and 34% of them were missense substitutions. CONCLUSION: Herein, we reported for the first time, the pattern of gene defects in Pakistani type 3 VWD cohort. We identified a wide heterogeneous mutation spectrum along with variability in the type of bleeding episodes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de von Willebrand Tipo 3 / Mutação Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Paquistão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de von Willebrand Tipo 3 / Mutação Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Paquistão